Navigation Links
Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
Date:6/15/2012

AMSTERDAM, June 15, 2012 /PRNewswire/ --

At the 17th Congress of the European Hematology Association in Amsterdam Professor Max Topp of the University of Wuerzberg in Germany presents the impressive results with a bispecific antibody for Acute Lymphoblastic Leukemia patients.

The Phase 2 dose-ranging study MT103-206 evaluated the efficacy, safety and tolerability of blinatumomab in adult patients with B-precursor Acute Lymphoblastic Leukemia who had relapsed following treatment with standard front-line chemotherapy or allogeneic stem cell transplant. Patients received blinatumomab for 28 days followed by two weeks off therapy over a six week treatment cycle, for up to five treatment cycles. Patients received a continuous intravenous infusion of blinatumomab at an initial dose of five or 15 micrograms/m2 per day, escalating to 30 micrograms for the remainder of the treatment. The primary endpoint of the study was the rate of complete remission (CR) and complete remission with partial hematologic recovery (CRh*). Secondary endpoints included molecular response rate, duration of response and overall survival. All 36 patients were evaluable for efficacy and safety.

Twenty-six of the 36 patients (72%) treated with blinatumomab across all of the tested doses and schedules achieved a CR/CRh*. All but two patients achieved a molecular response, meaning there was no evidence of leukemic cells by polymerase chain reaction. The most common adverse events were pyrexia, headache and tremor. Medically important safety events were reversible cytokine release syndrome and CNS adverse events.

At the time of the analysis, median survival was 9.0 (8.2, 15.8) months with a median follow-up period of 10.7 months. The median duration of response in the 26 patients who responded to treatment was 8.9 months.

About the EHA Annual Congress

After 16 congresses and constantly increasing number of delegates, the 17th'/>"/>

SOURCE European Hematology Association
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Nautilus Neurosciences, Inc. Announces a New Approval for CAMBIA® for the Acute Treatment of Migraine
2. CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms
3. MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020
4. Start of Phase IIa Study in Acute Lung Injury Patients Marks Development Milestone
5. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
6. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
7. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
8. MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020
9. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012
10. Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet
11. GeneLink Reports First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2013)... This training is ideal for those who will ... software industry or those who want to explore Agile and ... The topics that will be covered in the 1-day Agile ... scrum artifacts, and scrum simulation (optional). , The trainings ... June 28, 2013 , Click here to register for a ...
(Date:6/14/2013)... June 14, 2013 These couplings are ... come equipped with a new and improved “Easy Grip ... more secure grip and reliable connection every time. , ... for use on medical applications such as ... pressure cuff manufacturers with better, more reliable, high quality, ...
(Date:6/14/2013)... Rosacea is said to affect 16 million Americans, eczema, ... it seems that most of the population have one or ... reports, often deciphering the difference between one skin condition ... have similar symptoms. Probiotic Action explains how these skin conditions ... effectively. , Rosacea, Acne and Eczema are conditions that react ...
(Date:6/14/2013)... , June 14, 2013  The Pittsburgh Life Sciences ... levels of investment that were necessitated by delays in ... investment climate and the uncertainty of state funding. ... said, "As the region,s only pure life sciences investment ... by the PLSG Board of Directors, were necessary to ...
Breaking Biology Technology:Affordable Scrum Trainings in Denver, CO – 8 PDUs (June 28, 2013) by Conscires Agile Practices 2LinkTech Inc. Launches Ideal Replacement for a Luer Fitting 2LinkTech Inc. Launches Ideal Replacement for a Luer Fitting 3Rosacea, Acne, or Eczema? Probiotic Action Offers a Topical Probiotic to Treat the Most Common Skin Conditions 2Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding 2
... ... investment bank KTA Capital,s client Neuren Pharmaceuticals Ltd (ASX:NEU) has agreed an AU$6.7 mil ... by KTA Capital as Neuren,s exclusive placement agent and advisor. , ... New York (PRWEB) November 23, 2009 ...
... ... field remains the only one to show consistent growth during the U.S. recession. However, clinics ... actually cut medical personnel, instead of just administrators. , ... (Vocus) November 24, 2009 -- Health care employment continued growing in ...
... 24 Blue Marble Energy Corp. announced today that ... were recently awarded $2 million by Washington State,s Community ... construct the state,s first specialty biochemical biorefinery in Lincoln ... speed the development of our biorefinery and bring over ...
Cached Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
(Date:6/16/2013)... HIV prevention programs for female sex workers in India ... infections (STIs), a University of Toronto study has found. ... with HIV, mostly in the southern states of Andhra ... by Professor Prabhat Jha from U of T,s Dalla ... Centre for Global Health Research (CGHR), examined the impact ...
(Date:6/16/2013)... snap" 116 million years ago triggered a similar marine ... a result of global warming, according to research published ... involving experts from the universities of Newcastle, UK, Cologne, ... and a crash in the marine ecosystem during the ... the first time the amplitude and duration of the ...
(Date:6/14/2013)... Oklahoma researchers will collaborate with researchers from Oklahoma ... the University of Tulsa to advance understanding of ... climate change and variability in the state. , ... receive a $20 million National Science Foundation Experimental ... strategically aligned, innovative research over the next five ...
Breaking Biology News(10 mins):HIV prevention among female sex workers in India reduces HIV and syphilis 2Global cooling as significant as global warming 2OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3
... An international team of scientists, including botanists from the University ... be used to catalogue the world,s plants using a technique ... method that uses a short genetic marker in an organism,s ... "Barcoding provides an efficient means by which we can ...
... promising data from a clinical study showing patient-specific ... and immune cells were well tolerated and resulted ... metastatic melanoma whose disease had been minimized by ... "Phase II Trial of Dendritic Cells Loaded with ...
... Mitochondrial diseases disrupt the power generating machinery within cells ... in the lungs or respiratory tract. A new study ... shows that infection with the pneumonia causing bacteria ... a signaling protein that is associated with mitochondrial disease. ...
Cached Biology News:University of Toronto helps to 'barcode' the world's plants 2Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma 2Stress signals link pre-existing sickness with susceptibility to bacterial infection 2
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
...
Biology Products: